Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-01-03 @ 11:23 AM
Study NCT ID:
NCT00995293
Status:
COMPLETED
Last Update Posted:
2018-03-02
First Post:
2009-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-22
First Submit QC Date:
None
Study First Post Date:
2009-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-01
Last Update Post Date:
2018-03-02
Last Update Post Date Type:
ACTUAL